Canopy Biosciences Revenue and Competitors

Location

#4269

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Canopy Biosciences's estimated annual revenue is currently $13.5M per year.(i)
  • Canopy Biosciences's estimated revenue per employee is $155,000
  • Canopy Biosciences's total funding is $4.4M.

Employee Data

  • Canopy Biosciences has 87 Employees.(i)
  • Canopy Biosciences grew their employee count by 58% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$69.9M4518%N/AN/A
#2
$0.9M6-14%N/AN/A
#3
$6.2M40-32%N/AN/A
#4
$0.9M6-14%N/AN/A
#5
$4.2M27-7%N/AN/A
#6
$0.9M6-45%N/AN/A
#7
$4.8M3111%N/AN/A
#8
$3.4M22-15%N/AN/A
#9
$0.4M525%N/AN/A
#10
$4.3M2865%N/AN/A
Add Company

Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing key technologies in the fields of genetic engineering and personalized medicine. Founded in 2016, Canopy has offices and laboratories in St. Louis, MO.

keywords:N/A

$4.4M

Total Funding

87

Number of Employees

$13.5M

Revenue (est)

58%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Canopy Biosciences News

2022-04-13 - Latest Bruker innovations for multiplexed spatial proteomics

Canopy Biosciences' CellScape is the latest generation ChipCytometry™ instrument, which enables high-plex spatial imaging and quantification...

2022-04-06 - Bruker Announces Key Innovations for Multiplexed Spatial ...

Canopy Biosciences' CellScape is the latest generation ChipCytometry TM instrument, which enables high-plex spatial imaging and...

2022-03-22 - Canopy Biosciences Launches Next-Generation ChipCytometry ...

Canopy Biosciences is headquartered in St. Louis, Missouri, with a CLIA site in California, and a site in Germany to serve researchers at...

2019-04-30 - Canopy Biosciences Acquires Zellkraftwerk

Canopy Biosciences, a St. Louis, MO-based provider of gene editing and gene expression products and services, acquired Zellkraftwerk GmbH, a Leipzig, Germany-based multiplex cytometry company. Concurrent with the acquisition, Canopy closed a strategic growth investment from Ampersand Capital Pa ...

2018-05-22 - Canopy Biosciences Closes $2.4M Series A Funding

Canopy Biosciences, a St. Louis-based life sciences company, closed a $2.4m Series A financing. BioGenerator, the investment arm of BioSTL, and Kingdom Capital co-led the round, which saw participation from The Missouri Technology Corporation (MTC), PinPoint Holdings, Greenleaf Fund, and Arch A ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.7M879%N/A
#2
$12.6M8724%N/A
#3
$25.2M8716%N/A
#4
$23.8M8829%N/A
#5
$7.5M892%N/A